BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: El Hasbani G, Taher AT, Jawad A, Uthman I. COVID-19, Antiphospholipid Antibodies, and Catastrophic Antiphospholipid Syndrome: A Possible Association? Clin Med Insights Arthritis Musculoskelet Disord 2020;13:1179544120978667. [PMID: 33328777 DOI: 10.1177/1179544120978667] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Ebrahim FA, Moturi G, Mongare N, Shah R, Kao SCS. Unusual Presentation of Multisystemic Inflammatory Syndrome. Case Reports in Medicine 2022;2022:1-4. [DOI: 10.1155/2022/8442855] [Reference Citation Analysis]
2 Al-Beltagi M, Saeed NK, Bediwy AS. COVID-19 disease and autoimmune disorders: A mutual pathway. World J Methodol 2022; 12(4): 200-223 [DOI: 10.5662/wjm.v12.i4.200] [Reference Citation Analysis]
3 Signorelli F, Balbi GGM, Aikawa NE, Silva CA, Kupa LVK, Medeiros-Ribeiro AC, Yuki EF, Pasoto SG, Saad CG, Borba EF, Seguro LPC, Pedrosa T, Oliveira VAA, Costa ALCS, Ribeiro CT, Santos REB, Andrade DCO, Bonfá E. Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome. Lupus 2022;31:974-84. [PMID: 35593174 DOI: 10.1177/09612033221102073] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Schultheiß C, Willscher E, Paschold L, Gottschick C, Klee B, Henkes SS, Bosurgi L, Dutzmann J, Sedding D, Frese T, Girndt M, Höll JI, Gekle M, Mikolajczyk R, Binder M. The IL-1β, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep Med 2022;3:100663. [PMID: 35732153 DOI: 10.1016/j.xcrm.2022.100663] [Reference Citation Analysis]
5 Ritchie CA, Johnson MM, Stowell JT, Idrees H, Toskich B, Paz-fumagalli R, Montazeri S, Fortich S, Franco-mesa C, Gloviczki P, Bjarnason H, Rivera C, Shaikh M, Moreno-franco P, Sanghavi D, Marquez CP, Mcbane RD, Park MS, O’horo JC, Meschia JF, Erben Y. Resolution of Acute Pulmonary Embolism using anticoagulation therapy alone in Coronavirus Disease 2019. Journal of Vascular Surgery: Venous and Lymphatic Disorders 2022. [DOI: 10.1016/j.jvsv.2021.12.086] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Noureldine HA, El Hasbani G, Nour Eldine M, Nour-Eldine W, Taher A, Uthman I. Postural tachycardia syndrome (POTS) and antiphospholipid syndrome (APS): What do we know so far? Rev Neurol (Paris) 2021:S0035-3787(21)00772-4. [PMID: 34895744 DOI: 10.1016/j.neurol.2021.10.006] [Reference Citation Analysis]
7 Schultheiß C, Paschold L, Willscher E, Simnica D, Wöstemeier A, Muscate F, Wass M, Eisenmann S, Dutzmann J, Keyßer G, Gagliani N, Binder M. Maturation trajectories and transcriptional landscape of plasmablasts and autoreactive B cells in COVID-19. iScience 2021;24:103325. [PMID: 34723157 DOI: 10.1016/j.isci.2021.103325] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Chidharla A, Syed SB, Chatterjee T, Tarantino MD. A Case Report of COVID-Associated Catastrophic Antiphospholipid Syndrome Successfully Treated with Eculizumab. J Blood Med 2021;12:929-33. [PMID: 34744467 DOI: 10.2147/JBM.S324873] [Reference Citation Analysis]
9 Calvisi SL, Ramirez GA, Scavini M, Da Prat V, Di Lucca G, Laurenzi A, Gallina G, Cavallo L, Borio G, Farolfi F, Pascali M, Castellani J, Lampasona V, D'Angelo A, Landoni G, Ciceri F, Querini PR, Tresoldi M, Piemonti L. Thromboembolism risk among patients with diabetes/stress hyperglycemia and COVID-19. Metabolism 2021;123:154845. [PMID: 34364927 DOI: 10.1016/j.metabol.2021.154845] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
10 Meroni PL, Borghi MO. Antiphospholipid antibodies and COVID-19 thrombotic vasculopathy: one swallow does not make a summer. Ann Rheum Dis 2021;80:1105-7. [PMID: 34340980 DOI: 10.1136/annrheumdis-2021-220520] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Favaloro EJ, Henry BM, Lippi G. Is Lupus Anticoagulant a Significant Feature of COVID-19? A Critical Appraisal of the Literature. Semin Thromb Hemost 2021. [PMID: 34130341 DOI: 10.1055/s-0041-1729856] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
12 Toshida M, Konishi Y, Ikenouchi A, Okamoto N, Yoshimura R. Colchicine-Resistant Familial Mediterranean Fever With Depressive State Successfully Treated With Escitalopram. Cureus 2021;13:e15145. [PMID: 34164245 DOI: 10.7759/cureus.15145] [Reference Citation Analysis]
13 Nasonov EL. 2019 Coronavirus disease (COVID-19): contribution of rheumatology. Terapevticheskii arkhiv 2021;93. [DOI: 10.26442/00403660.2021.05.200799] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Trahtemberg U, Rottapel R, Dos Santos CC, Slutsky AS, Baker A, Fritzler MJ. Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients. Ann Rheum Dis 2021;80:1236-40. [PMID: 33903092 DOI: 10.1136/annrheumdis-2021-220206] [Cited by in Crossref: 4] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
15 Acherjee T, Bastien B, Rodriguez-Guerra MA, Salman S, Ali N. Digital Ischemia as an Initial Presentation in a COVID-19-Positive Patient Without Any Significant Respiratory Symptoms. Cureus 2021;13:e14054. [PMID: 33898138 DOI: 10.7759/cureus.14054] [Reference Citation Analysis]
16 Nasonov EL. Coronavirus disease 2019 (COVID-19) and autoimmunity. Naučno-praktičeskaâ revmatologiâ 2021;59:5-30. [DOI: 10.47360/1995-4484-2021-5-30] [Cited by in Crossref: 14] [Cited by in F6Publishing: 1] [Article Influence: 14.0] [Reference Citation Analysis]